Loading
Latest filing published 08 Apr 2026 for Beauty Farm Medical and Health Industry Inc., €42k.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Li Fangyu is a declared insider of Beauty Farm Medical and Health Industry Inc. (chief executive), with filings sourced from HKEX. We count 11 filings; the first trade dates from 4 July 2023 and the latest from 2 April 2026.
No open-market sale appears; the market trades are 11 purchases worth €620k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 6 purchases and no sales.
The median purchase comes to €42k. Scaled by market value, the purchases weigh a median 0.0055% of market cap (sample: 4 purchases). On 11 out of 11 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of -15.0%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
On 8 April 2026 came the latest disclosure, an open-market purchase for €42k in Beauty Farm Medical and Health Industry Inc. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 3 declarations